首页> 外文期刊>British Journal of Clinical Pharmacology >Immediate-type hypersensitivity drug reactions
【24h】

Immediate-type hypersensitivity drug reactions

机译:立即型超敏反应

获取原文
获取原文并翻译 | 示例
       

摘要

Hypersensitivity reactions including anaphylaxis have been reported for nearly all classes of therapeutic reagents and these reactions can occur within minutes to hours of exposure. These reactions are unpredictable, not directly related to dose or the pharmacological action of the drug and have a relatively high mortality risk. This review will focus on the clinical presentation, immune mechanisms, diagnosis and prevention of the most serious form of immediate onset drug hypersensitivity reaction, anaphylaxis. The incidence of drug-induced anaphylaxis deaths appears to be increasing and our understanding of the multiple and complex reasons for the unpredictable nature of anaphylaxis to drugs is also expanding. This review highlights the importance of enhancing our understanding of the biology of the patient (i.e. immune response, genetics) as well as the pharmacology and chemistry of the drug when investigating, diagnosing and treating drug hypersensitivity. Misdiagnosis of drug hypersensitivity leads to substantial patient risk and cost. Although oral provocation is often considered the gold standard of diagnosis, it can pose a potential risk to the patient. There is an urgent need to improve and standardize diagnostic testing and desensitization protocols as other diagnostic tests currently available for assessment of immediate drug allergy are not highly predictive.
机译:几乎所有类型的治疗剂均已报告包括过敏反应在内的超敏反应,这些反应可在暴露后数分钟至数小时内发生。这些反应是不可预测的,与药物的剂量或药理作用没有直接关系,并且具有相对较高的死亡风险。这篇综述将集中于最严重形式的即刻药物超敏反应,过敏反应的最严重表现的临床表现,免疫机制,诊断和预防。药物引起的过敏性反应死亡的发生率似乎正在增加,并且我们对药物过敏性的不可预测性质的多种复杂原因的理解也在扩大。这篇评论强调了在研究,诊断和治疗药物超敏反应时,增强我们对患者生物学(即免疫反应,遗传学)以及药物的药理学和化学认识的重要性。药物超敏反应的误诊会导致大量的患者风险和费用。尽管口头挑衅通常被认为是诊断的黄金标准,但它可能给患者带来潜在的风险。迫切需要改进和标准化诊断测试和脱敏方案,因为当前可用于评估即时药物过敏的其他诊断测试并不是高度可预测的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号